NewHydrogen, Inc. 10-Q

ITEM 5. OTHER INFORMATION None. 19 ITEM 6. EXHIBITS Exhibit No. Description 10.1 Securities Purchase Agreement dated August 17, 2020 (Filed as an exhibit to the Company’s Current Report on Form 8-K filed with the SEC on August 21, 2020) 10.2 Convertible Promissory Noted dated August 17, 2020 (filed as an exhibit to the Company’s Current Report on form 8-K filed with the SEC on August 21, 2020) 10.3 Convertible Promissory Note dated September 14, 2020 (Filed as an exhibit to the Company’s Current Report on Form 8-K filed with the SEC on September 17, 2020) 10.4 Securities Purchase Agreement dated September 17, 2020 (Filed as an exhibit to the Company’s Current Report on Form 8-K filed with the SEC on September 17, 2020) 31.1 Certification by Chief Executive Officer and Acting Chief Financial Officer pursuant to Sarbanes-Oxley Section 302 (filed herewith). 32.1 Certification by Chief Executive Officer and Acting Chief Financial Officer pursuant to 18 U.S.C. Section 1350 (filed herewith). EX-101.INS XBRL Instance Document EX-101.SCH XBRL Taxonomy Extension Schema Document EX-101.CAL XBRL Taxonomy Extension Calculation Linkbase EX-101.DEF XBRL Taxonomy Extension Definition Linkbase EX-101.LAB XBRL Taxonomy Extension Labels Linkbase EX-101.PRE XBRL Taxonomy Extension Presentation Linkbase 20 SIGNATURES In accordance with Section 13 or 15(d) of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Los Angeles, State of California, on November 9, 2020. BIOSOLAR, INC. By: /s/ David Lee Chief Executive Officer (Principal Executive Officer) and Acting Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) 21